IR Magazine and Governance Intelligence

Following a challenging period, healthcare companies have experienced increased momentum heading into year-end, with valuations picking up, funding conditions improving and investors showing enthusiasm for innovative treatments and services. But companies are experiencing wide performance dispersion, with investors remaining selective about which projects and businesses they will back. In this webinar, IR and communications experts…